| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | GW PHARMACEUTICALS PLC | 6,000 | 670,000 | 0.14% | ||
| 102 | DAVITA INC | 10,000 | 642,000 | 0.13% | ||
| 103 | NEVRO CORP COM | 8,700 | 632,000 | 0.13% | ||
| 104 | VARIAN MED SYS INC | 7,000 | 628,000 | 0.13% | ||
| 105 | KITE PHARMA INCORPORATED | 14,000 | 628,000 | 0.13% | ||
| 106 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 566,000 | 0.12% | ||
| 107 | INSULET CORPORATION | 15,000 | 565,000 | 0.12% | ||
| 108 | REWALK ROBOTICS LTD | 200,000 | 560,000 | 0.11% | ||
| 109 | QUOTIENT LTD | 110,000 | 532,000 | 0.11% | ||
| 110 | Esperion Therapeutics Inc | 40,000 | 501,000 | 0.10% | ||
| 111 | RESMED INC | 8,000 | 496,000 | 0.10% | ||
| 112 | Theravance Biopharma Inc | 15,428 | 492,000 | 0.10% | ||
| 113 | NOVAVAX INC COM | 325,000 | 410,000 | 0.08% | ||
| 114 | HORIZON PHARMA PLC | 24,000 | 388,000 | 0.08% | ||
| 115 | WEBMD HEALTH CORP | 7,400 | 367,000 | 0.08% | ||
| 116 | OBALON THERAPEUTICS INC | 40,000 | 354,000 | 0.07% | ||
| 117 | AAC HLDGS INC | 45,000 | 326,000 | 0.07% | ||
| 118 | PENUMBRA INC COM | 5,000 | 319,000 | 0.07% | ||
| 119 | SURGERY PARTNERS INCORPORATED | 15,000 | 238,000 | 0.05% | ||
| 120 | MYRIAD GENETICS INC | 14,000 | 233,000 | 0.05% | ||
| 121 | Wright Medical Group NV | 10,000 | 230,000 | 0.05% | ||
| 122 | EIGER BIOPHARMACEUTICALS INC | 3,333 | 39,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001410, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
